$59.95
-0.74-1.22%
Pre-Market: 7:16 PM EDT
Comments
Loading...
Novonesis (Novozymes) B Analyst Ratings and Price Targets | OTC:NVZMY | Benzinga
Novonesis (Novozymes) B Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Novonesis (Novozymes) B Corp from these most-recent analyst ratings.
Analyst Ratings for Novonesis (Novozymes) B
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Novonesis (Novozymes) B (NVZMY) stock?
There is no price target for Novonesis (Novozymes) B
What is the most recent analyst rating for Novonesis (Novozymes) B (NVZMY)?
There is no analyst for Novonesis (Novozymes) B
When was the last upgrade for Novonesis (Novozymes) B (NVZMY)?
There is no last upgrade for Novonesis (Novozymes) B
When was the last downgrade for Novonesis (Novozymes) B (NVZMY)?
There is no last downgrade for Novonesis (Novozymes) B.
When is the next analyst rating going to be posted or updated for Novonesis (Novozymes) B (NVZMY)?
There is no next analyst rating for Novonesis (Novozymes) B.
Is the Analyst Rating Novonesis (Novozymes) B (NVZMY) correct?
There is no next analyst rating for Novonesis (Novozymes) B.
Browse analyst ratings and price targets on all stocks.